Foxi, IPF Immune is not being produced in the US, it's being produced by VetProm in Bulgaria, same company producing their ITV-1.
This is what also probably caused delays along with labeling/supply issues back in March. New international product, an immune modulator, during the pandemic, I'm sure drew a lot of scrutiny from the FDA. Looks like the issues have been resolved and they are ready to launch on Monday.
Lots of talk about it only being on Onelavi.com, but this is just the initial launch imo, and as time goes by and they can assess demand, they will hopefully grow into other retailers and markets.
Supplement market was never initially on the radar, but it's a huge market and it can hopefully generate revenue until they can profit from ITV-1 or Clone 3. Any revs will certainly be welcomed.
News 
Market Data 
Discover 
